Panacea Biotec gets Award notification from Pan American Health Organization

12 Nov 2025 Evaluate

Panacea Biotec has received an Award notification from Pan American Health Organization, (PAHO) Regional Office of World Health Organization under a Long-term agreement for supply of Diphtheria-Tetanus-Pertussis-Hepatitis B-Haemophilus influenzae type B (DTP-HepB-Hib) Vaccine (Pentavalent) - Liquid (single dose) (Easyfive-TT) to PAHO, valid until December 31, 2027.

The total award to the company is for supply of Easyfive-TT Vaccine aggregating around $4.75 million (around Rs.41 crore) during Calendar Year 2026 and 2027.

Panacea Biotec is a leading research-based Biotechnology Company with established research, manufacturing and marketing capabilities.


Panacea Biotec Share Price

345.50 2.25 (0.66%)
18-Dec-2025 10:35 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1754.20
Dr. Reddys Lab 1273.05
Cipla 1501.10
Zydus Lifesciences 917.20
Lupin 2112.45
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×